The biology and pathobiology of glutamatergic, cholinergic, and dopaminergic signaling in the aging brain

A Gasiorowska, M Wydrych, P Drapich… - Frontiers in aging …, 2021 - frontiersin.org
The elderly population is growing worldwide, with important health and socioeconomic
implications. Clinical and experimental studies on aging have uncovered numerous …

The cholinergic system, the adrenergic system and the neuropathology of Alzheimer's disease

RA Bekdash - International Journal of Molecular Sciences, 2021 - mdpi.com
Neurodegenerative diseases are a major public health problem worldwide with a wide
spectrum of symptoms and physiological effects. It has been long reported that the …

[HTML][HTML] Nicotinic acetylcholine receptors in neurological and psychiatric diseases

AV Terry Jr, K Jones, D Bertrand - Pharmacological Research, 2023 - Elsevier
Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that are
widely distributed both pre-and post-synaptically in the mammalian brain. By modulating …

Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance

C Geula, SR Dunlop, I Ayala, AS Kawles… - Journal of …, 2021 - Wiley Online Library
The basal forebrain cholinergic neurons (BFCN) provide the primary source of cholinergic
innervation of the human cerebral cortex. They are involved in the cognitive processes of …

PET neuroimaging of Alzheimer's disease: radiotracers and their utility in clinical research

W Bao, F Xie, C Zuo, Y Guan… - Frontiers in aging …, 2021 - frontiersin.org
Alzheimer's Disease (AD), the leading cause of senile dementia, is a progressive
neurodegenerative disorder affecting millions of people worldwide and exerting tremendous …

New approaches to symptomatic treatments for Alzheimer's disease

J Cummings - Molecular Neurodegeneration, 2021 - Springer
Background Successful development of agents that improve cognition and behavior in
Alzheimer's disease (AD) is critical to improving the lives of patients manifesting the …

State-of-the-art imaging of neuromodulatory subcortical systems in aging and Alzheimer's disease: Challenges and opportunities

N Engels-Domínguez, EA Koops, PC Prokopiou… - Neuroscience & …, 2023 - Elsevier
Primary prevention trials have shifted their focus to the earliest stages of Alzheimer's disease
(AD). Autopsy data indicates that the neuromodulatory subcortical systems'(NSS) nuclei are …

Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer's disease dementia

DL Sultzer, AC Lim, HL Gordon, BC Yarns… - Alzheimer's Research & …, 2022 - Springer
Background Cholinergic neurotransmitter system dysfunction contributes to cognitive
impairment in Alzheimer's disease and other syndromes. However, the specific cholinergic …

PET imaging of cholinergic neurotransmission in neurodegenerative disorders

S Tiepolt, PM Meyer, M Patt… - Journal of Nuclear …, 2022 - Soc Nuclear Med
As a neuromodulator, the neurotransmitter acetylcholine plays an important role in cognitive,
mood, locomotor, sleep/wake, and olfactory functions. In the pathophysiology of most …

[HTML][HTML] PET agents in dementia: an overview

A van Waarde, S Marcolini, PP De Deyn… - Seminars in nuclear …, 2021 - Elsevier
This article presents an overview of imaging agents for PET that have been applied for
research and diagnostic purposes in patients affected by dementia. Classified by the target …